These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16462573)

  • 1. Cisplatin: continuous versus bolus.
    Gratton MA; Smyth BJ
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):60-1. PubMed ID: 16462573
    [No Abstract]   [Full Text] [Related]  

  • 2. Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors.
    Gupta AA; Capra M; Papaioannou V; Hall G; Maze R; Dix D; Weitzman S
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):91-4. PubMed ID: 16462581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platinum derivatives].
    Sasaki Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():452-5. PubMed ID: 15658361
    [No Abstract]   [Full Text] [Related]  

  • 6. Cisplatinum ototoxicity in children, long-term follow up.
    Al-Khatib T; Cohen N; Carret AS; Daniel S
    Int J Pediatr Otorhinolaryngol; 2010 Aug; 74(8):913-9. PubMed ID: 20846503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin ototoxicity in children: implications for primary care providers.
    Helt-Cameron J; Allen PJ
    Pediatr Nurs; 2009; 35(2):121-7. PubMed ID: 19472677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
    Montaguti M; Brandolini C; Ferri GG; Hatzopoulos S; Prete A; Pession A
    Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Verify the optimum administration of anticancer agent--cisplatin].
    Miyanaga N; Akaza H
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1339-44. PubMed ID: 11681239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
    Kanamori M; Kumabe T; Saito R; Yamashita Y; Sonoda Y; Tominaga T
    No Shinkei Geka; 2010 Nov; 38(11):997-1005. PubMed ID: 21081811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphological and functional correlations of the protective action of pantothenic acid in cisplatin ototoxicity (I)].
    Martínez Martínez MJ; Fernández Cervilla F; Crespo VP; Giges M; Campos A
    Acta Otorrinolaringol Esp; 1997 May; 48(4):261-4. PubMed ID: 9376134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cis-diamminedichloroplatinum (II) given as low-dose and high-dose infusions.
    Kurihara N; Kubota T; Hoshiya Y; Otani Y; Ando N; Kumai K; Kitajima M
    J Surg Oncol; 1996 Jun; 62(2):135-8. PubMed ID: 8649040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation.
    de Jonge MJ; Slingerland M; Loos WJ; Wiemer EA; Burger H; Mathijssen RH; Kroep JR; den Hollander MA; van der Biessen D; Lam MH; Verweij J; Gelderblom H
    Eur J Cancer; 2010 Nov; 46(16):3016-21. PubMed ID: 20801016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P; Lassalle M; Mercier G; Raquin MA; Izzi G; Corradini N; Hartmann O
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):649-55. PubMed ID: 15454836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
    Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
    Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
    Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profound hearing loss from intravertebral artery cisplatin.
    Wetmore SJ; Koike KJ; Bloomfield SM
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):234-7. PubMed ID: 9051071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.